Reperfusion delay in patients treated with primary percutaneous coronary intervention: Insight from a real world Danish ST-segment elevation myocardial infarction population in the era of telemedicine

European Heart Journal: Acute Cardiovascular Care

Volumn 1, Issue 3, 2012, Pages 200-209

  Schoos, Mikkel M ^a   Sejersten, Maria ^a   Hvelplund, Anders ^b   Madsen, Mette ^b   Lønborg, Jacob ^a   Steinmetz, Jacob ^a   Treschow, Philip M ^c   Pedersen, Frants ^a   Jørgensen, Erik ^a   Grande, Peer ^a   Kelbæk, Henning ^a   Clemmensen, Peter ^a  

^a Mental Health Center Glostrup   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c District General Hospital Nykøbing Falster   (Denmark)

Author keywords

Acute myocardial infarction; pre hospital triage; primary PCI; reperfusion delay; STEMI; telemedicine

Indexed keywords

EID: 84990348162     PISSN: 20488726     EISSN: 20488734     Source Type: Journal    
DOI: 10.1177/2048872612455143     Document Type: Article

References (36)

1. Eitel I, Desch S, Fuernau G, et al. Prognostic significance and determinants of myocardial salvage assessed by cardiovascular magnetic resonance in acute reperfused myocardial infarction. J Am Coll Cardiol 2010; 55: 2470–2479.
2. Francone M, Bucciarelli-Ducci C, Carbone I, et al. Impact of primary coronary angioplasty delay on myocardial salvage, infarct size, and microvascular damage in patients with ST-segment elevation myocardial infarction: insight from cardiovascular magnetic resonance. J Am Coll Cardiol 2009; 54: 2145–2153.
3. Terkelsen CJ, Jensen LO, Tilsted HH, et al. Health care system delay and heart failure in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: follow-up of population-based medical registry data. Ann Intern Med 2011; 155: 361–367.
4. Terkelsen CJ, Sørensen JT, Maeng M, et al. System delay and mortality among patients with STEMI treated with primary percutaneous coronary intervention. JAMA 2010; 304: 763–771.
5. Guidelines on myocardial revascularization.The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2010; 31: 2501–2555.
6. Sejersten M, Sillesen M, Hansen PR, et al. Effect on treatment delay of prehospital teletransmission of 12-lead electrocardiogram to a cardiologist for immediate triage and direct referral of patients with ST-segment elevation acute myocardial infarction to primary percutaneous coronary intervention. Am J Cardiol 2008; 101: 941–946.
7. Gheeraert PJ, De Buyzere ML, Taeymans YM, et al. Risk factors for primary ventricular fibrillation during acute myocardial infarction: a systematic review and meta-analysis. Eur Heart J 2006; 27: 2499–2510.
8. Andersen HR, Nielsen TT, Rasmussen K, et al. A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction. N Engl J Med 2003; 349: 733–742.
9. Huber K, Goldstein P, Danchin N, et al. Network models for large cities: the European experience. Heart 2010; 96: 164–169.
10. Kalla K, Christ G, Karnik R, et al. Implementation of guidelines improves the standard of care. Circulation 2006; 113: 2398–2405.
11. Ting HH, Rihal CS, Gersh BJ, et al. Regional systems of care to optimize timeliness of reperfusion therapy for ST-elevation myocardial infarction. Circulation 2007; 116: 729–736.
12. Jollis JG, Roettig ML, Aluko AO, et al. Implementation of a statewide system for coronary reperfusion for ST-segment elevation myocardial infarction. JAMA 2007; 298: 2371–2380.
13. Le May MR, So DY, Dionne R, et al. A citywide protocol for primary PCI in ST-segment elevation myocardial infarction. N Engl J Med 2008; 358: 231–240.
14. Saif SR, Jeptha PC, Jersey C, et al. Association of door-toballoon time and mortality in patients admitted to hospital with ST elevation myocardial infarction: national cohort study. BMJ 2009; 338: b1807.
15. Antman EM, Hand M, Armstrong PW, et al. 2007 Focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction. Circulation 2008; 117: 296–329.
16. Van de Werf F, Bax J, Betriu A, et al. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation. Eur Heart J 2008; 29: 2909–2945.
17. Terkelsen CJ, Christiansen EH, Sørensen JT, et al. Primary PCI as the preferred reperfusion therapy in STEMI: it is a matter of time. Heart 2009; 95: 362–369.
18. Terkelsen CJ, Jensen LO, Tilsted HH, et al. Primary percutaneous coronary intervention as a national reperfusion strategy in patients with ST-segment elevation myocardial infarction. Circ Cardiovasc Interv 2011; 4: 361–367.
19. Terkelsen CJ. CardioPulse: should the rebellious Danes stay with the balloons or should they adhere to the 2008 ESC ST-elevation myocardial infarction guidelines and re-introduce the lytics? Eur Heart J 2010; 31: 1541–1547.
20. Bjørklund E, Stenestrand U, Lindbäck J, et al. Pre-hospital thrombolysis delivered by paramedics is associated with reduced time delay and mortality in ambulance-transported real-life patients with ST-elevation myocardial infarction. Eur Heart J 2006; 27: 1146–1152.
21. Keeley EC, Boura JA and Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 2003; 361: 13–20.
22. Boersma E and The Primary Coronary Angioplasty vs Thrombolysis (PCAT) Group. Does time matter? A pooled analysis of randomized clinical trials comparing primary percutaneous coronary intervention and in-hospital fibrinolysis in acute myocardial infarction patients. Eur Heart J 2006; 27: 779–788.
23. Stenestrand U, Lindbäck J, Wallentin L, et al. Long-term outcome of primary percutaneous coronary intervention vs prehospital and in-hospital thrombolysis for patients with ST-elevation myocardial infarction. JAMA 2006; 296: 1749–1756.
24. Nielsen PH, Terkelsen CJ, Nielsen TT, et al. System delay and timing of intervention in acute myocardial infarction (from the Danish Acute Myocardial Infarction-2 (DANAMI-2) trial). Am J Cardiol 2011; 108: 776–781.
25. Pinto DS, Frederick PD, Chakrabarti AK, et al. Benefit of transferring ST-segment elevation myocardial infarction patients for percutaneous coronary intervention compared with administration of onsite fibrinolytic declines as delays increase. Circulation 2011; 124: 2512–2521.
26. Welsh RC, Travers A, Senaratne M, et al. Feasibility and applicability of paramedic-based prehospital fibrinolysis in a large North American center. Am Heart J 2006; 152: 1007–1014.
27. Bonnefoy E, Steg PG, Boutitie F, et al. Comparison of primary angioplasty and pre-hospital fibrinolysis in acute myocardial infarction (CAPTIM) trial: a 5-year follow-up. Eur Heart J 2009; 30: 1598–1606.
28. Westerhout CM, Bonnefoy E, Welsh RC, et al. The influence of time from symptom onset and reperfusion strategy on 1-year survival in ST-elevation myocardial infarction: A pooled analysis of an early fibrinolytic strategy versus primary percutaneous coronary intervention from CAPTIM and WEST. Am Heart J 2011; 161: 283–290.
29. Danchin N, Coste P, Ferrières J, et al. Comparison of thrombolysis followed by broad use of percutaneous coronary intervention with primary percutaneous coronary intervention for ST-segment elevation acute myocardial infarction. Circulation 2008; 118: 268–276.
30. Borgia F, Goodman SG, Halvorsen S, et al. Early routine percutaneous coronary intervention after fibrinolysis vs. standard therapy in ST-segment elevation myocardial infarction: a meta-analysis. Eur Heart J 2010; 31: 2156–2169.
31. Assessment of the Safety and Efficacy of a New Treatment Strategy with Percutaneous Coronary Intervention (ASSENT-4 PCI) investigators. Primary versus tenecteplase-facilitated percutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction (ASSENT-4 PCI): randomised trial. Lancet 2006; 367: 569–578.
32. Henry TD, Sharkey SW, Burke MN, et al. A regional system to provide timely access to percutaneous coronary intervention for ST-elevation myocardial infarction. Circulation 2007; 116: 721–728.
33. Herrmann HC, Lu J, Brodie BR, et al. Benefit of facilitated percutaneous coronary intervention in high-risk ST-segment elevation myocardial infarction patients presenting to nonpercutaneous coronary intervention hospitals. JACC Cardiovasc Interv 2009; 2: 917–924.
34. Hassan AKM, Liem SS, Van der Kley F, et al. In-ambulance abciximab administration in STEMI patients prior to primary PCI is associated with smaller infarct size, improved LV function and lower incidence of heart failure: results from the Leiden MISSION! acute myocardial infarction treatment optimization program. Catheter Cardiovasc Interv 2009; 74: 335–343.
35. Heestermans T, De Boer MJ, Van Werkum JW, et al. Higher efficacy of pre-hospital tirofiban with longer pre-treatment time to primary PCI: protection for the negative impact of time delay. EuroIntervention 2011; 7: 442–448.
36. Sejersten M, Nielsen SL, Engstrøm T, et al. Feasibility and safety of prehospital administration of bivalirudin in patients with ST-elevation myocardial infarction. Am J Cardiol 2009; 103: 1635–1640.